These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12584964)

  • 1. Lack of awareness and nonadherence in schizophrenia.
    Kozuki Y; Froelicher ES
    West J Nurs Res; 2003 Feb; 25(1):57-74. PubMed ID: 12584964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
    Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
    J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics.
    Lang K; Meyers JL; Korn JR; Lee S; Sikirica M; Crivera C; Dirani R; Menzin J
    Psychiatr Serv; 2010 Dec; 61(12):1239-47. PubMed ID: 21123409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prototype approach toward antipsychotic medication adherence in schizophrenia.
    Freudenreich O; Tranulis C
    Harv Rev Psychiatry; 2009; 17(1):35-40. PubMed ID: 19205965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and nonadherence to antipsychotic medications.
    Kozuki Y; Schepp KG
    Issues Ment Health Nurs; 2005 May; 26(4):379-96. PubMed ID: 16020055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J; Bitter I
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia.
    Tsang HW; Fung KM; Corrigan PW
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):3-14. PubMed ID: 18417098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
    Adelufosi AO; Adebowale TO; Abayomi O; Mosanya JT
    Gen Hosp Psychiatry; 2012; 34(1):72-9. PubMed ID: 22036736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.
    Olfson M; Marcus SC; Wilk J; West JC
    Psychiatr Serv; 2006 Feb; 57(2):205-11. PubMed ID: 16452697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study.
    Grunebaum MF; Weiden PJ; Olfson M
    J Clin Psychiatry; 2001 May; 62(5):394-9; quiz 400-1. PubMed ID: 11411825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder.
    Wiffen BD; Rabinowitz J; Fleischhacker WW; David AS
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):169-75. PubMed ID: 20880827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
    Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
    Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: Impact of psychopathology, faith healers and psycho-education on adherence to medications.
    Abdel Aziz K; Elamin MH; El-Saadouni NM; El-Gabry DA; Barakat M; Alhayyas F; Moselhy HF
    Int J Soc Psychiatry; 2016 Dec; 62(8):719-725. PubMed ID: 27815512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.